Federal contractor · public award history
NOVO NORDISK INC
Parent: NOVO NORDISK INC. CXEGLZDTX1E1
- Awards we know about
- 5
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Sep 24, 2026
- Activation date
- Sep 26, 2025
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (5)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
BPA FOR RIVFLOZA
- Department of Veterans Affairs—
NEW NATIONAL CONTRACT AWARD FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK. PERIOD OF PERFORMANCE IS 11/02/2020 THROUGH 11/01/2021 WITH FOUR ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW AWARD FOR HUMAN INSULIN WITH NOVO NORDISK, INC. PERIOD OF PERFORMANCE IS 7/1/2020 - 6/30/2021 WITH FOUR ONE-YEAR OPTIONS.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.